The Walls Closed In On Amarex

Madness. What were they thinking? They left their sanity behind because they were overtaken by fear of CytoDyn emerging.

They had to get rid of CytoDyn once and for all, so they wanted to take that last remaining $13 million and sue them they would. Easy money they thought. Don't even need to do their jobs properly, and they would still get paid in full. So they thought. They didn't know they were stepping straight into it.

Amarex wasn't planning on handing over the data. Really, they were hoping CytoDyn would just go out of business completely. Then, they would have succeded in their overall mission. But that didn't happen. No, they were forced to hand over their shoddy raw data by court injunction. Never in a million years did they consider that David Welch would provide that $6.5 million bond in exchange for the evidence that would eventually bring them down.

The roles have been reversed. The Defendant became the Plaintiff and the Plaintiff became the Defandant. Now, they are shitting bricks. Actually, they can't even think about shitting, so they're all blocked up and it won't ever come out. Now, instead of being on the receiving end of $13 million, they will be doing the sending of 10 times that. Instead of CytoDyn being oblitterated out of existence, they need to worry that they themselves are not blotted out of existence themselves. CytoDyn was not supposed to get this far.

Sidley Austin has a load of power right now. Evidence as determined by (4) Independent External Auditors as well as determined by Auditors of the FDA which were performed upon Amarex's work.

"12:12 Antonio Migliarese: Thank you Tanya. Next we are going to jump into the Amarex litigation which Tyler Block, our corporate counsel, will be providing some input on as well. We previously announced that we filed a statement claims against Amarex which we are quite pleased about. For those who don't remember, Amarex was our former CRO and we are seeking damages in excess of $100 million from them*. Following of the statement of claim, the very important next step in the litigation, the company believes that it is in a good position to fully pursue this litigation, as in addition to the financing, the company has secured from the litigation, the company has also posted and secured $6.5 million to collateralize assurety bond related to this matter.* We are very bullish on the outcome of this litigation*. In particular,* due to the results of independent audits, that have been performed on Amarex's work, as well as the results of Audits performed by the FDA, which resulted in regulatory action against Amarex*, which we have become aware of. The company will do everything in its power, to pursue the maximum recovery possible from Amarex and its parent company NSF.*

13:33: As mentioned, our corporate counsel, Tyler Blok, has joined us here today, and he will provide some more color around the specifics of the Amarex litigation. Tyler.

13:45 Tyler Blok (Attorney, Corporate Counsel): Thank you Antonio. As Antonio just explained, the company is well positioned to aggressively pursue our claim against Amarex and we have instructed Sidley Austin, the law firm representing the company, to take all steps necessary to maximize recovery*. It is through this claim, that we will be* pursuing all damages the company incurred as a result of Amarex's misconduct*. Whether it be due to* Amarex's failure to perform services to an acceptable professional standard, Amarex billing the company for services that it did not perform or whether it relates to the 10's of millions of dollars, the company was forced to incur to remedy the issues created by Amarex's numerous and blatant failures. In total, we will be seeking not less than $100 million in damages. We are confident in our case and have one of the preeminent litigation firms in the world representing the company in this preceding. On behalf of the company, Sidley Austin recently filed a detailed statement of claim and requested the final hearing date be set*. Should we prevail at the final hearing, we will be* entitled to recover our damages caused by Amarex, as well as our legal fees incurred in pursuing the matter. Finally, I wanted to acknowledge that we have indeed received a number of questions from investors in relation to the law suit against Amarex. As the litigation is still pending, it would not be prudent, to disclose additional details at this time, needless to say, that we do not want to put the company, or its claims against Amarex at risk, but management will look for opportunities to provide additional updates when appropriate. We understand the importance of this case to both the company and its investors and therefore will be working vigorously on pursuing this matter and will look to provide further update when possible. Thanks Antonio."

Was this your end goal Amarex? This thing is fixin to get so good. The journey is hard, but it is leading somewhere.

Truth wins in the end. Fight the good fight. We are in a race to the finish line. Stay in the fight. Victory is in sight.